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Abstract
Background: The development of optimal vaccination strategies for pneumococcal conjugate vaccines requires serotype-
specific data on disease incidence and carriage prevalence. This information is lacking for the African meningitis belt.
Methods: We conducted hospital-based surveillance of acute bacterial meningitis in an urban and rural population of
Burkina Faso during 2007–09. Cerebrospinal fluid was evaluated by polymerase chain reaction for species and serotype. In
2008, nasopharyngeal swabs were obtained from a representative population sample (1 month to 39 years; N = 519) and
additional oropharyngeal swabs from 145 participants. Swabs were evaluated by culture.
Results: Annual pneumococcal meningitis incidence rates were highest among ,6-month-old (58/100,000) and 15- to 19-
year-old persons (15/100,000). Annual serotype 1 incidence was around 5/100,000 in all age groups. Pneumococcal carriage
prevalence in nasopharyngeal swabs was 63% among ,5-year-old children and 22% among $5-year-old persons, but
adding oropharyngeal to nasopharyngeal swabs increased the estimated carriage prevalence by 60%. Serotype 1 showed
high propensity for invasive disease, particularly among persons aged $5 years.
Conclusions: Serotype 1 causes the majority of cases with a relatively constant age-specific incidence. Pneumococcal
carriage is common in all age groups including adults. Vaccination programs in this region may need to include older target
age groups for optimal impact on disease burden.
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Introduction
The African meningitis belt is located at the southern border of
the Sahara and extends from Senegal to Ethiopia. It is
characterized by seasonal hyperendemicity of acute bacterial
meningitis during the dry season and sporadic localised and
regional epidemics [1,2]. While meningitis epidemics are exclu-
sively due to meningococci, seasonal hyperendemicity is due to
both pneumococci and meningococci [3–6]. Pneumococcal
meningitis has high incidence among older children and adults
with an estimated life time risk of 0.6% and is due primarily to
serotype 1 [7].
Several countries in the African meningitis belt, including
Burkina Faso, plan to introduce serotype 1 containing pneumo-
coccal conjugate vaccines into their routine infant immunization
programs, with the goal to protect children during the first year of
life, primarily from pneumonia. Given the high burden of
pneumococcal meningitis in older children and adults in the
African meningitis belt – and an unknown burden of pneumo-
coccal pneumonia – the question arises whether the vaccination
schedule for this region should be adapted to directly protect these
age groups from meningitis and other pneumococcal syndromes
[7]. This discussion is complex and should include biomedical,
financial, logistic and sociological aspects. One approach is to
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compare vaccination strategies by modeling their impact taking
into account age- and serotype-specific incidence, strain trans-
mission (carriage) and vaccine effectiveness. For the African
meningitis belt, few serotype-specific estimates of incidence or
carriage exist, mainly due to technical difficulties with isolation
and serotyping of pneumococci. A new technology of PCR-based
serotyping directly on cerebrospinal fluid (CSF) [8] has reduced
this barrier.
In this context, we aimed at describing serotype-specific
pneumococcal meningitis incidence and carriage prevalence
among children and adults in Burkina Faso. We also evaluated
whether oropharyngeal added to nasopharyngeal swabbing
improved pneumococcal carriage detection.
Methods
Ethics Statement
We obtained ethical approval for the carriage and surveillance
studies from the Burkina Faso national review committee and the
Centre Muraz ethics committee.
Surveillance
During March 2007 to December 2009, we conducted
a hospital-based bacterial meningitis surveillance study in four
administrative health districts in and around Bobo-Dioulasso,
Burkina Faso. During March 2007-February 2008, we surveyed
the 588,022 inhabitants of the urban zone; during March 2008-
December 2009, and following additional funding, we expanded
the surveyed population to the 900,176 inhabitants of both the
urban and rural zones. The latter represented about 6% of the
country’s population. As previously reported [9], all suspected
meningitis patients of the surveyed population presenting to any
health care service in the surveyed zone were supposed to receive
a lumbar puncture. The study zone included the country’s second
largest university hospital, which is the major reference center for
the Western region of Burkina Faso, all district hospitals and all
health centers; health centers performed lumbar puncture and
provided clinical care, but did not provide in-patient care for
meningitis patients. An urban private clinic did not participate in
the surveillance, but reportedly saw few suspected meningitis cases.
All CSF samples were analyzed using a multiplex PCR technique
for identification and serotyping of pneumococcal meningitis cases
at Centre Muraz in Bobo-Dioulasso. This involved DNA
extraction by a cycle of freezing and thawing and centrifugation,
gene amplification of lytA for Streptococcus pneumoniae (Sp) [10,11],
and, if a pneumococcal etiology was identified, an algorithm of 29
primers screening for 43 serotypes or -groups (see Supporting
Information, Table S1) [8]. In addition, culture and latex
agglutination [12] were performed on CSF samples that arrived
in the laboratory within three hours after lumbar puncture.
Pneumococci isolated in this case underwent serotyping by PCR
[8], as well. For quality control, all pneumococcal isolates were
confirmed and serotyped at the German Reference Center for
Streptococci (Aachen) by Neufeld Quellung reaction using antisera
provided by the Statens Serum Institute (Copenhagen, Denmark)
[13]; similarly, a subset of CSF samples was tested for
pneumococcal etiology and serotype by PCR [8].
Carriage Study 2008
During February 2008, we recruited by cluster sampling
a representative sample (N=519) of the urban population in
Bobo-Dioulasso aged 1 month to 39 years. Ten out of the town’s
22 neighborhoods were selected randomly, and between 22 and 24
crossroads in each neighborhood were randomly chosen as
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starting points. At each starting point, the street of recruitment was
randomly determined and the compounds along this street were
visited, starting with the first compound after the crossroad. In
each compound, a list of inhabitants aged 1–11 months, 1–9 years,
10–19 years, 20–29 years and 30–39 years was established and one
participant randomly chosen for each age group. If the chosen
person refused participation or if the age group was not
represented in the compound, the closest neighboring compound
was visited. Persons with residence outside urban Bobo-Dioulasso,
non-African ethnicity, or severe disease, including hemophilia,
were excluded.
Following written, informed consent, a baseline questionnaire
was administered that determined medical history and life style of
participants and their families. During February 21 and March 5,
2008, all participants visited the Centre Muraz outpatient clinic,
where the questionnaire was completed, and weight and height
were measured for children less than ten years old using available
clinic scales. For children shorter than 121 cm, malnutrition was
defined as weight-for-height below the third percentile according
to WHO child growth standards [14]. Swabbing was then
performed by ear-nose-and-throat specialist nurses. Nasopharyn-
geal swabs via the nose were taken from all 519 participants using
flexible sterile swabs with a calcium alginate tip. In addition, for
a representative sub-sample of 145 participants aged 1 to 39 years,
we also took oropharyngeal swabs from the posterior pharyngeal
wall via the mouth using cotton-tipped sterile swabs [15]. Isolation
and identification of pneumococci followed the WHO consensus
recommendations where possible [16]. Swabs were immediately
streaked onto sheep blood agar with 7% gentamycine. The dishes
were stored immediately in a 5%-CO2 atmosphere at room
temperature for a maximum of two hours until incubation at
37uC. From each incubated plate with colonies suspicious of S.
pneumoniae by aspect (alpha-hemolysis, umbilicated), three bacterial
colonies were selected from distinct locations on the plate. They
were submitted to optochine, Gram stain and catalase. Colonies
with an optochine diameter$14 mm, or an optochine diameter of
8–13 mm and positive bile solubility, were purified and prepared
for transport on Portagerm AMIESH agar swabs (Biome´rieux) or
storage on Brain-Heart-Infusion and glycerol at 280uC. All
isolated pneumococci were confirmed and serotyped at the
German Reference Center for Streptococci using standard
techniques and Neufeld Quellung [13].
Statistical Analyses
We used standard statistical methods, including adjusting for the
design effect of cluster sampling. Incidence rates and 95%-
confidence intervals were calculated using national census data
(2006) extrapolated to the surveillance years and assuming
a Poisson distribution. Differences in participant characteristics
by nasopharyngeal carriage status were tested by logistic regression
while adjusting for age. To assess the theoretical propensity of
individual serogroups to cause invasive disease given carriage,
relative to other serogroups, we calculated serotype-specific
invasiveness indexes as odds ratios (IIOR= ad/bc) where a = n
cases(serotype), b = n cases(other serotypes), c = n carriers(sero-
type), d = n carriers(other serotypes) [17]. Exact 95% confidence
Figure 1. Monthly incidence rates of bacterial meningitis in Bobo-Dioulasso, Burkina Faso, March 2007 to December 2009. a)
Pneumococcal (black line) and meningococcal (grey line) meningitis. b) Age-specific rates of pneumococcal meningitis, by season. Black lines, dry
season. Grey lines, rainy season. Full lines, all pneumococcal cases. Dashed lines, serotype 1 cases only. Asterixes, 95% confidence intervals of
incidence rates of all pneumococcal cases do not overlap between dry vs. rainy season, suggesting statistical significance of difference.
doi:10.1371/journal.pone.0052464.g001
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intervals were calculated, using Cornfield approximation in case of
empty cells. All analyses were done in STATA version 11.
Results
Meningitis Incidence
During March 2007-December 2009, we enrolled 1,008
suspected meningitis cases, of which CSF was analyzed by PCR
for 976 (97%), by culture for 983 (98%) and by latex for 927
(92%), and 999 (99%) had at least one of these tests. Among the
454 confirmed bacterial cases (45%), we identified 159 (35%)
pneumococci (32 confirmed by PCR only, 8 by culture only and 8
by latex only), 286 (63%) meningococci and 9 (2%) Haemophilus
influenzae. One hundred twenty-seven pneumococcal cases (80%)
had pneumococcal serotyping performed. Among the 82 culture-
positive pneumococcal cases, 25 pneumococci were stored and
later serotyped by PCR or Quellung. No discordance in serotype
result was found for cases tested by more than one method.
We calculated annual incidence rates per 100,000 inhabitants
over two entire years from March 2007 to February 2009 to avoid
any bias from seasonal variation. Overall annual pneumococcal
meningitis incidence was 8.9 (95%-CI, 7.5–10.6), 7.3 (6.0–8.8) for
serotyped cases, 3.7 (2.8–4.8) for serotype 1, and 4.7 (3.7–6.0) and
4.9 (3.8–6.1) for serotypes included in PCV-10 and PCV-13,
respectively (Table 1). Infants aged ,6 months had the highest
annual incidence rate of pneumococcal meningitis (58/100,000,
Table 1) but a second peak was observed among 15- to 19-year-
old persons (15/100,000). These two peaks also were found for
PCV-10 or PCV-13 serotypes. Serotype 1 meningitis incidence
varied little by age with the highest rate found among 15- to 19-
year-old persons (8/100,000). No systematic difference in in-
cidence existed for urban versus rural populations. Sixty-seven
percent of any pneumococcal cases (77% of cases preventable by
PCV-10 or -13) occurred among $5-year-old persons.
During the dry season months of December-May, the monthly
incidence rates per 100,000 population of any pneumococcal and
serotype 1 meningitis were 1.1 (95% CI, 0.9–1.3) and 0.4 (0.3–0.6)
while during the wet season months of June-November, incidence
rates were 0.1 (0.1–0.2) and 0.0 (0.0–0.1) (Figure 1). The ratio of
the average monthly incidence during dry compared to rainy
seasons was 9.1 (95%-CI 3.9–26.0) for serotype 1 meningitis and
7.5 (3.6–18.2) for other serotypes, without variation by age group.
Serotype 1 showed a flat age distribution during both the dry and
the rainy season (Figure 1, Table 1).
The case fatality ratio from presentation to the end of health
center care was 40% (62/155), without substantial variation by
season, age or serotype, including serotype 1 (27/61 cases). Among
survivors at hospital discharge, a motor or sensory handicap was
identified for 9 of 28 (32%) ,5-year-old children and for 3 of 65
(5%) $5-year-old persons (Chi-square test for difference in
proportion, P,0.001).
The most commonly identified serotypes or serogroups among
children ,5-years-old were 14 (19% of serotyped cases), 1 (16%)
and 18 (8%), with 22% being non-typable (i.e., serotypes not
included in the PCR algorithm); among persons $5-years old, the
most common serotypes were 1 (70%) and 12F (10%), with 11%
being non-typable (Figure 2a–c).
Carriage
Among the 519 participants of the carriage study, clinical
rhinitis at swabbing was common (29% of children age ,5 years,
11% of persons age $5 years), 22% of children ,121 cm tall had
malnutrition, 8% of $15-year-old persons smoked tobacco, 40%
of $10-year-old persons were illiterate and two-thirds of
participants had a television set in the compound (see Supporting
Information, Table S2). Any pneumococcal carriage was found in
166 (32%) participants and nasopharyngeal carriage prevalence
decreased from 73% among 6- to 11-month-old children to 11%
among 25- to 29-year-old adults (Table 2). Nasopharyngeal
carriers of pneumococcus were younger than non-carriers (mean,
9.1 versus 18.2 years, Student’s t-test, P,0.001), while other
characteristics of life style or medical history did not differ
significantly between carriers and non-carriers after adjustment for
age. The carriage prevalences for any pneumococci, 10-valent
vaccine serotypes, and 13-valent vaccine serotypes, were 63%,
23% and 35%, respectively, among ,5-year-old children and
22%, 6% and 7%, respectively, among $5-year-old persons
(Table 2).
Among the 145 1- to 39-year-old participants with additional
oropharyngeal swabbing, 25 (17%) were exclusively nasopharyn-
geal carriers and 25 (17%) exclusively oropharyngeal carriers,
while 16 (11%) carried at both sites (Figure 3). Among 1- to 14-
year-old children, nasopharyngeal compared to oropharyngeal
prevalence was 10% higher, while among 15- to 39-year-old
persons, oropharyngeal compared to nasopharyngeal prevalence
was 7% higher. Adding a second technique increased documented
carriage prevalence 1.6-fold from 28% (95% CI, 21%–36%) to
46% (37%–54%). To use these data to estimate overall carriage
prevalence in our study population, for each age group we
multiplied the nasopharyngeal carriage prevalence by the extrap-
olation factor, with the latter defined as ‘‘(nasopharyngeal+or-
opharyngeal)/nasopharyngeal carriers’’. For ,1-year-old chil-
dren, we assumed this factor to be the same as among 1- to 4-
year-old children. Using this method, the extrapolated overall
carriage prevalence ranged from 97% among 6- to 11-month-old
children to 23% among 25- to 29-year-old adults (Table 2).
From the 191 persons with oropharyngeal or nasopharyngeal
carriage identified, 406 pneumococcal isolates were obtained.
Among these 406 isolates, 391 from 180 carriers were serotyped,
including 336 from nasopharyngeal and 55 from oropharyngeal
swabs. Among nasopharyngeal carriers of pneumococci, 19% had
one, 43% two and 37% three colonies positive for pneumococcus;
these figures were 47%, 24% and 29% among oropharyngeal
carriers. Of the 180 carriers, 43 were age ,1 year, 41,1–4 years,
and 96$5 years; within these three age groups, carriage of two
serotypes was observed for 3 (7%), 3 (7%) and 11 (11%) persons,
respectively and no participants had more than two serotypes
identified. Among patients who had an additional oropharyngeal
swab, two serotypes were found in 17% of participants versus 8%
of participants who did not have an oropharyngeal swab
(difference P=0.039). Among persons with a nasopharyngeal
swab, two serotypes were found in 0%, 9% and 5%, respectively,
of participants with 1, 2 and 3 nasopharyngeal isolates retrieved
(difference P=0.335); among persons who also had an oropha-
Figure 2. Serotype or -group distribution among carriage (dark gray) and pneumococcal cases (light gray), Burkina Faso, 2007–9.
Serotyping based on cerebrospinal fluid polymerase chain reaction testing [8] or Quellung reaction on invasive isolates; and on Quellung reaction for
carriage isolates. Each panel A–C shows only serotypes that were found in this age category. A: children ,1 years of age, 92 nasopharyngeal carriage
and 32 cases. B: children 1–4 years of age, 98 carriage isolates (90 nasopharyngeal, 8 oropharyngeal) and 10 cases. C: children $5 years of age and
adults, 203 carriage isolates (157 nasopharyngeal, 46 oropharyngeal) and 84 cases. NT, invasive isolates with serotypes not included in the PCR
serotyping algorithm (29 primers); or carriage isolates yielding negative results in the Quellung reaction panel.
doi:10.1371/journal.pone.0052464.g002
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ryngeal swab, two serotypes were found in 43%, 75% and 20%,
respectively, of participants with 1, 2 and 3 oropharyngeal isolates
(difference P=0.255).
Among ,1-year-old participants, the most frequently observed
serotypes (carried by at least 5% of participants) were 23F, 19A,
7C, 6A and 19F, which together accounted for 51% of carriers.
Among 1- to 4-year-old participants, these figures were 19F, 23F,
6A and 6B, accounting for 42% of carriers, and among 5- to 39-
year-old carriers, these were non-typable strains, 16F, 6B, 23F,
and 7C, accounting for 34% of carriers. These distributions were
similar if unit of observation was bacterial isolates rather than
persons with carriage (Figure 2a–c). Serotype 1 carriage was
found in one 4- and one 10-year-old child. Among persons 5–39
years old (numbers insufficient for younger children), the following
serotypes were significantly (P,0.05) more frequent among
oropharyngeal (N= 46) than nasopharyngeal (N= 157) isolates:
23A (7% vs. 0%), 6B (13% vs. 3%) and NT (16% vs. 6%).
A significantly higher theoretical relative propensity for invasive
disease (ie, the lower 95% confidence limit of the invasiveness
index was .1.00) was found for serotypes 1 (IIOR 83.5, 95%
confidence interval 20.6–716.6), 5 (‘; 1.2-‘), 12A/B/F (4.7; 1.1–
24.5) and non-typable pneumococci (2.6; 1.1–6.1) (Table 3). The
IIOR of serotype 1 was 12.8 (1.4–596.1) for ,5-year-old children
and 146.9 (22.0–5991.3) for $5-year-old persons.
Discussion
This study in the African meningitis belt found that over 77% of
vaccine-preventable cases occurred among $5-year-old persons
and that the incidence rate of serotype 1 meningitis was constantly
high across all age groups. Applying standard microbiological
techniques (bile solubility testing and Quellung serotyping) and
conventional nasopharyngeal swabbing, we found relatively high
carriage prevalence among $5-year-old persons and a 60%
increase in carriage prevalence estimates when an oropharyngeal
swab was added.
Our incidence estimates for overall pneumococcal meningitis
are comparable to other periods or places in the meningitis belt
[3,6,7,18], although they are in the lower range for ,1-year-old
infants and for the elderly. Both for serotype 1 and other serotypes,
hyperendemic incidences during the dry season were almost ten-
fold higher compared to endemic incidences during the rainy
season, while this endemic incidence was comparable in magni-
tude and age distribution to the annual incidence rate of
pneumococcal meningitis in Europe [19]. Few studies have
investigated the impact of climate in the meningitis belt on
pneumococcal disease. One explanation could be seasonal
variation of pneumococcal transmission. Only one study from
The Gambia reported a two-fold increase in carriage prevalence
across seasons, however without specifying the months and
associated climate [20]. For meningococci, some evidence suggests
that the hyperendemic increase of incidence during the dry season
[10- to 100-fold (Figure 1)] is due to increased risk of invasive
disease given colonization rather than increased bacterial trans-
mission [2]. The damage conferred to the pharyngeal mucosal
barrier by persisting extremely low air humidity or high air dust
load is a potential explanation, and this model may also apply to
pneumococci. In theory, this could have implications for vaccine
protection. If a damaged mucosal barrier allows direct invasion
from the pharynx into the meninges, as previously hypothesized
[2,21], then bacteria could bypass serum immune defense, and the
principal action of vaccine-induced protection would occur on the
mucosal surface. Such a hypothesis underlines the importance of
evaluating thoroughly the effective impact of meningococcal and
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pneumococcal conjugate vaccine introduction in the African
meningitis belt.
Similar to serogroup A meningococci, serotype 1 carriage is
rarely detected except during outbreaks [22]. Given the high
incidence rates we observed in our study, serotype 1 must have
circulated relatively constantly in our study population, while
rarely forming colonies in the pharynx or alternatively forming
colonies that are difficult to detect by standard swabbing methods.
In a study among 1- to 39-year-old Burkinabe`, we previously
found that seroprevalence of IgG antibody concentrations
$0.35 mg/ml against serotype 1 increased with age from 20%
to 70%, similar to other serotypes [23]. In this context, the finding
that serotype 1 incidence does not decrease after infancy despite
increasing antibody concentrations may indicate that adults fail to
acquire functional antibody. This is consistent with a theoretical
relative propensity for invasive disease of serotype 1 that was
comparable to reports for children under age five years on other
continents [15,24]. One should keep in mind that relative
propensity as a proxy for invasiveness provides limited evidence
due to its theoretical and ecological nature, as it is not based on
individual patient data. In any case, the epidemiology of
pneumococcal meningitis in the meningitis belt likely results from
a complex interaction between strain biology and competition,
climate impact on host and bacteria, population mixing patterns
and hygienic conditions, and other still unknown factors.
We likely underestimated incidence, as a substantial number of
patients may not have presented for medical care, particularly
infants with a non-specific clinical presentation [4]. Although
PCR-based serotyping of CSF increased the proportion of
serotyped cases compared to Neufeld Quellung, the PCR
algorithm was limited, at the time of our study, to 43 pre-selected
serotypes or -groups, classifying all other cases as non-typable. In
control analyses with Quellung, serotypes 2, 13, 46 and 48 were
identified among such non-typable cases [8] and they are
historically rare serotypes. However, as many as 30% of
pneumococcal meningitis cases among children ,1 year were
classified as non-typable, and non-typable pneumococci showed
a high theoretical relative propensity for invasive disease,
emphasizing the need to periodically identify the involved
serotypes by Quellung and to regularly update the PCR algorithm
(see http://www.cdc.gov/ncidod/biotech/strep/pcr.htm for
primer updates).
To our knowledge, this is the first study reporting pneumococcal
carriage estimates specifically for the meningitis belt and we found
high pneumococcal carriage prevalence. In the Gambia, naso-
pharyngeal swabbing studies [20] described point prevalence of
around 80% among ,1-year-old children and up to 25% among
their mothers, and Hill [25] reported prevalence ranging from
95% in infants to 50% in adults $40 years of age. Similar to this
latter study, we could not identify any risk factor for pneumococcal
carriage other than age.
We found that nasopharyngeal swabbing alone underestimated
pneumococcal carriage prevalence in all age groups by at least
30% and that oropharyngeal compared to nasopharyngeal
swabbing yielded higher prevalence in teenagers and adults,
which is in concordance with a study on Native American adults
[26]. Nasopharyngeal swabbing alone appeared to underestimate
particularly the prevalence of serotypes 23A, 6B and non-typable
pneumococci. In our study, adding oropharyngeal to nasopha-
ryngeal swabbing had a greater effect on detection of multiple
serotype carriage than the number of colonies evaluated (the
overall frequency of multiple carriage was comparable to studies in
Europe [27]). This may be different if .10 colonies were
evaluated and if inexperienced technicians read the plates, but
the fact that picking several colonies with similar morphology does
not increase serotype yield has been described for PCR serotyping
of carriage colonies [28]. Carriage studies in this region should use
both naso- and oropharyngeal swabs, whenever logistically and
ethically feasible. Recently developed techniques of broth enrich-
ment culture and PCR-based pneumococcal detection may further
increase the estimated carriage prevalence [28].
A major component of the public health benefit of PCVs is the
indirect protection of unvaccinated persons due to reduced
transmission following vaccine introduction [29]. In this setting
where $5-year-old persons experience 77% of PCV-preventable
meningitis burden, mostly due to serotype 1, and frequently carry
Figure 3. Age-specific pneumococcal carriage prevalence by carriage site in pharynx among 145 participants with both naso- and
oropharyngeal swabs. Bobo-Dioulasso, 2008.
doi:10.1371/journal.pone.0052464.g003
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pneumococci, a vaccination strategy targeting only ,5-year-old
children may not provide substantial indirect protection, if
younger children respond sub-optimally to serotype 1 vaccine or
if serotype 1 circulation among older children and adults does not
depend on carriage among younger children. If this hypothesis is
true, the vaccination strategy could be adapted by adding catch-up
campaigns in older age groups. It also will be important to
continue to monitor serotype distribution, as even among younger
children many identified serotypes are not covered in current
vaccine formulations. The presented data are useful for populating
mathematical models predicting the impact of such different PCV
strategies on disease burden. Pneumococcal pneumonia incidence
estimated specifically for the meningitis belt would be of great
value, as high meningitis incidence and carriage prevalence in
adults may or may not translate into high pneumonia incidence
[7]. Preliminary data from Northern Togo suggest that pneumo-
coccal pneumonia is similarly seasonal and of high incidence in
older age groups [30]. Overall, the presented data underline that
the understanding of pneumococcal pathophysiology in the
African meningitis belt should be improved to optimize vaccine
impact.
Supporting Information
Table S1 Algorithm of sequential multiplex polymerase
chain reaction testing (PCR) for Streptococcus pneumo-
niae serotype determination for meningitis belt coun-
tries, with and internal positive control using cpsA in
each reaction.
(DOCX)
Table S2 Characteristics of carriage study participants
aged 1 month to 39 years (N=519), by nasopharyngeal
pneumococcal carriage status. Bobo-Dioulasso, Febru-
ary 2008.
Table 3. Propensity of pneumococcal serotypes for invasive disease (meningitis) given carriage, relative to other serotypes or -
groups.
Serotype
or -group
N Cases due to this
Serotype
N Cases due to
Other Serotypes
N Carriers of
this Serotype
N Carriers of
Other Serotypes
Invasiveness Index as Odds Ratio
(95% Confidence Interval)
1 57 56 2 164 83.5 (20.6, 716.6)
2 1 112 0 166 ‘{
3 1 112 4 162 0.3 (0.01, 3.7)
4 0 113 2 164 0 (0, 2.8)
5 3 110 0 166 ‘ (1.2, ‘)
6 * 4 109 20 146 0.3 (0.1, 0.8)
7C 0 113 10 156 0 (0, 0.5)
9V 0 113 3 163 0 (0, 1.9)
12A/B/F{ 9 104 3 163 4.7 (1.1, 27.5)
13 0 113 3 163 0 (0, 1.9)
14 6 107 10 156 0.9 (0.3, 2.8)
15A 0 113 4 162 0 (0, 1. 4)
15B/C * 1 112 6 160 0.2 (0.01, 2.0)
16F 0 113 6 160 0 (0, 0.9)
17F 0 113 6 160 0 (0, 0.9)
18 * 4 109 8 158 0.7 (0.2, 2.8)
19A 0 113 9 157 0 (0, 0.6)
19B 0 113 5 161 0 (0, 1.1)
19F 1 112 11 155 0.1 (0.0, 0.9)
22F 0 113 3 163 0 (0, 1.9)
23F 1 112 18 148 0.07 (0.0, 0.5)
34 0 113 5 161 0 (0, 1.1)
35B 0 113 2 164 0 (0, 2.8)
35F 0 113 5 161 0 (0, 1.1)
38/25F * 3 110 3 163 1.5 (0.2, 11.3)
48 1 112 0 166 ‘{
NT 19 94 12 154 2.6 (1.1, 6.1)
The invasiveness index was calculated using all cases of pneumococcal meningitis with serotype or -group information identified during the dry season months of
2007–2009 (N = 113) and pneumococcal carriage (N = 166) identified in Bobo-Dioulasso, Burkina Faso, March 2007– February 2009. Serotyping was based on
cerebrospinal fluid polymerase chain reaction testing [8] or Quellung reaction on invasive isolates; and on Quellung reaction for carriage isolates. The table reports
serotypes that were found in at least one meningitis case, found in at least three carriers, or included in 10- or 13-valent pneumococcal conjugate vaccines.
*Discrimination within the serogroup or between serotypes not possible for some meningitis cases due to PCR algorithm.
{PCR serotyping on invasive isolates or CSF cannot discriminate between 12A/B/F, while Quellung typing of carriage isolates identified 12F only.
{Cornfield estimation of the confidence interval possible only under certain conditions.
doi:10.1371/journal.pone.0052464.t003
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